[Continuous subcutaneous insulin infusion in type 1 diabetic during pregnancy: case report and literature review].
The type 1 diabetic patient pregnancy is subjected to various attempts to obtain good glycemic control, since the pre-conception period throughout the gestation. Continuous subcutaneous insulin infusion (CSII) is a therapeutic tool to achieve the glycemic targets. Here it is presented the case of a Type 1 diabetic woman, who was not under multiple insulin daily injections therapy, and whose insulin therapy started on CSII during the second trimester of gestation, obtaining successful therapeutic outcome.
Reis
Janice Sepúlveda
JS
Serviço de Endocrinologia e Metabologia, Santa Casa de Belo Horizonte, MG, Brasil. janicesepulveda@terra.com.br
Lamounier
Rodrigo Nunes
RN
Menezes
Patrícia A F C
PA
Calsolari
Maria R
MR
Purisch
Saulo
S
D000279:Administration, Cutaneous; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D015918:Infusion Pumps, Implantable; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems; D011247:Pregnancy; D011256:Pregnancy Outcome; D011262:Pregnancy Trimester, Second; D011254:Pregnancy in Diabetics; D055815:Young Adult
D007004:Hypoglycemic Agents; D007328:Insulin